News
To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered ...
China's biotech sector is rapidly advancing due to heavy R&D investment and a push for technological self-sufficiency. See ...
The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively ...
In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...
China has become a significant player in the biotech space, potentially threatening the lead the US holds. EY Americas ...
It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most ...
Despite the current economic slump, investing in biotech remains steady. A recent Harvard panel offered suggestions on where the money's being invested and predictions for hot trends.
The biotech industry in Massachusetts braces for another tough year. Acquisitions, funding, public offerings, and stock prices fell in 2022, sending small firms into survival mode — and hoping ...
Some safety experts in the biotechnology industry argue that there is no big safety problem, and that workers are adequately protected by various voluntary guidelines on safe laboratory practices ...
The industry’s workforce, however, is less futuristic than its goals. Black people account for 6% of the county’s overall workforce but just 3% of biotech, according to the San Diego Workforce ...
A biotechnology industry exchange-traded fund (ETF) invests in companies that combine biology and technology to develop innovative products and services.
Amid rapid growth of the region's life sciences industry and a soft market for traditional office space, lab development is sprouting all over Greater Boston.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results